95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.82%
Revenue growth under 50% of RGLD's 25.30%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
27.82%
Gross profit growth at 50-75% of RGLD's 39.19%. Martin Whitman would question if cost structure or brand is lagging.
33.04%
EBIT growth 75-90% of RGLD's 43.39%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
33.04%
Operating income growth at 75-90% of RGLD's 43.39%. Bill Ackman would demand a plan to enhance operating leverage.
37.61%
Net income growth at 75-90% of RGLD's 45.73%. Bill Ackman would press for improvements to catch or surpass competitor performance.
35.71%
EPS growth at 75-90% of RGLD's 43.75%. Bill Ackman would push for improved profitability or share repurchases to catch up.
35.71%
Diluted EPS growth at 75-90% of RGLD's 43.75%. Bill Ackman would expect further improvements in net income or share count reduction.
0.90%
Share count expansion well above RGLD's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.13%
Diluted share count expanding well above RGLD's 0.29%. Michael Burry would fear significant dilution to existing owners' stakes.
-47.91%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
20.34%
OCF growth above 1.5x RGLD's 11.98%. David Dodd would confirm a clear edge in underlying cash generation.
-582.88%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
179.16%
10Y revenue/share CAGR at 50-75% of RGLD's 330.31%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
0.97%
5Y revenue/share CAGR under 50% of RGLD's 55.05%. Michael Burry would suspect a significant competitive gap or product weakness.
13.13%
3Y revenue/share CAGR under 50% of RGLD's 107.98%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
185.85%
10Y OCF/share CAGR 1.25-1.5x RGLD's 155.20%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-22.53%
Negative 5Y OCF/share CAGR while RGLD is at 1.14%. Joel Greenblatt would question the firm’s operational model or cost structure.
9.91%
3Y OCF/share CAGR under 50% of RGLD's 54.67%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
84.25%
Net income/share CAGR at 50-75% of RGLD's 117.53%. Martin Whitman might question if the firm’s product or cost base lags behind.
-50.72%
Negative 5Y net income/share CAGR while RGLD is 12.22%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-13.06%
Negative 3Y CAGR while RGLD is 95.25%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
302.23%
10Y equity/share CAGR at 75-90% of RGLD's 390.41%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
57.24%
5Y equity/share CAGR above 1.5x RGLD's 28.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
20.67%
Positive short-term equity growth while RGLD is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
46.03%
Below 50% of RGLD's 108.73%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-56.25%
Negative near-term dividend growth while RGLD invests at 14.93%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-15.57%
Firm’s AR is declining while RGLD shows 9.15%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
13.75%
Asset growth above 1.5x RGLD's 2.57%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.65%
BV/share growth above 1.5x RGLD's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
90.51%
Debt growth far above RGLD's 12.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-8.58%
We cut SG&A while RGLD invests at 26.53%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.